Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04924803 · ClinicalTrials.gov registry record · NA
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
A NA study of Covid19, sponsored by NDRI-USA.
- Active
- Registry status
- NA
- Development phase
- 545
- Enrollment target
- 1
- Study location
NCT04924803 is a NA study of Covid19 that is active but no longer recruiting, run by NDRI-USA. The registered enrollment target is 545 participants, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04924803, a NA study of Covid19, is active but no longer recruiting, sponsored by NDRI-USA.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 545 participants
- Enrollment target
- 1
- Study location
Study Summary
People who inject drugs (PWID) experience disproportionate risk of being infected with SARS-CoV-2, the virus that causes COVID-19, yet due to stigma, fear of mistreatment, and other factors, PWID are far less likely to be vaccinated compared to other populations. In response, we propose to continue our collaboration with a prominent community based organization serving African American and Latino PWID. Our project will explore baseline hesitancy to vaccinate among PWID, identify barriers to vaccination, and then develop and evaluate messaging designed to increase COVID-19 vaccination among our target population of PWID through a clinical trial.
Conditions Studied
Interventions
- BEHAVIORAL No video
- BEHAVIORAL Video Text
Study Locations (1)
New York
- OnPoint NYC - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 545 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2026-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04924803
The ClinicalTrials.gov registry entry for NCT04924803 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 545 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (80% lower). The listed sponsor is NDRI-USA, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 2 interventions - of which No video is the first listed.
NCT04924803 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04924803 about?
NCT04924803 is a clinical study titled "Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs". People who inject drugs (PWID) experience disproportionate risk of being infected with SARS-CoV-2, the virus that causes COVID-19, yet due to stigma, fear of mistreatment, and other factors, PWID are far less likely to be vaccinated compared to other populations. In response, we propose to continue ...
What is the current status of trial NCT04924803?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 545 participants. The study started on 2022-06-21. Estimated completion is 2026-02-27.
What conditions does trial NCT04924803 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04924803?
The interventions under investigation include: No video (BEHAVIORAL), Video Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT04924803?
This trial is sponsored by NDRI-USA, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04924803 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
-
A Smartphone Intervention for Relational and Mental Well Being
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.